Showing results (61-70 of 81) with videos related to
Sort By:
Pageof 9
The Journal of Allergy and Clinical Immunology. in Practice|December 3, 2014
Fiscal implications of newborn screening in the diagnosis of severe combined immunodeficiencyCatherine Kubiak, Soma Jyonouchi, Caroline Kuo, et al.The Journal of Allergy and Clinical Immunology. in Practice|March 13, 2026
Recommended Vaccines for Immunocompetent Older Adults: Work Group Report of the AAAAI Allergy and Asthma in Older Adults CommitteeJonathan Slimovitch, Richard F Lockey, Anna Chen Arroyo, et al.Virology|March 7, 2002
Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 proteaseMaureen M Goodenow, Gregory Bloom, Stephanie L Rose, et al.Frontiers in Immunology|July 26, 2021
Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary ImmunodeficienciesElena E Perez, Jacques Hébert, Anne K Ellis, et al.Clinical Immunology (Orlando, Fla.)|July 12, 2017
Idiopathic T cell lymphopenia identified in New York State Newborn ScreeningStephanie Albin-Leeds, Juliana Ochoa, Harshna Mehta, et al.Journal of Clinical Immunology|March 7, 2012
Safety, efficacy and pharmacokinetics of a new 10% liquid intravenous immunoglobulin (IVIG) in patients with primary immunodeficiencyRichard L Wasserman, Joseph A Church, Mark Stein, et al.The Journal of Experimental Medicine|February 22, 2012
Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3KMary Ellen Conley, A Kerry Dobbs, Anita M Quintana, et al.Clinical Immunology (Orlando, Fla.)|November 17, 2009
Use of intravenous immunoglobulin and adjunctive therapies in the treatment of primary immunodeficiencies: A working group report of and study by the Primary Immunodeficiency Committee of the American Academy of Allergy Asthma and ImmunologyPierre L Yong, John Boyle, Mark Ballow, et al.Immunologic Research|October 9, 2008
Genetic engineering of T cells for adoptive immunotherapyAngel Varela-Rohena, Carmine Carpenito, Elena E Perez, et al.AIDS (London, England)|July 24, 2009
Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitorSarah K Ho, Elena E Perez, Stephanie L Rose, et al.Pageof 9